top of page

Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.

2022

J Infect

Tunesi S, Dû DL, Gualano G, et al.

DIO:

10.1016/j.jinf.2022.03.004

bottom of page